期刊文献+

HIV-1蛋白酶和逆转录酶抗药基因变异检测方法的建立及临床应用 被引量:3

Rapid detection of drug resistant HIV-1 to reverse transcriptase and protease inhibitors in HIV infected patients receiving highly active antiretroviral therapies
原文传递
导出
摘要 目的 应用现有DNA序列分析技术对人类免疫缺陷病毒 1型 (HIV 1)的蛋白酶 (PR)和逆转录酶 (RT)基因进行简便、快速、准确的序列分析 ,在临床上为HIV 1患者治疗方案的确定提供可靠依据。方法 从HIV 1感染者血清中提取RNA ,用套式逆转录 聚合酶链反应 (RT PCR)扩增HIV 1的PR和RT基因片段 ,并对此片段进行核苷酸序列分析。结果 本方法对血清中HIV 1RNA含量约 2 0 0 0拷贝 ml以上的样品都能有效扩增。在序列分析时背景干扰少 ,对 2 5 %左右的混合序列均能准确反映。通过对临床治疗病人进行动态序列分析观察 ,发现在药物治疗过程中 ,病人血浆中HIV 1RNA含量变化与PR和RT基因抗药性变异具有很大相关性。结论 PR和RT基因序列分析方法能够及时、准确地反映HIV 1患者在抗病毒药物治疗过程中病毒的变异情况。该方法的建立能在临床上能为不同患者治疗方案的确定提供直接。 Objective To develop and validate a rapid and sensitive method that can be used to detect emergence of HIV 1 drug resistant viruses in HIV infected patients receiving highly active antiretroviral therapies (HAART). Methods HIV 1 viral RNA was extracted from plasma and amplified by nested RT PCR. Nucleotide sequences of the reverse transcriptase (RT) and protease (PR) genes were determined by automated DNA sequencing. Results RT and PR sequences can be reliably determined with a minimum 2 000 copies/ml of viral RNA in plasma. Emergence of drug resistant viruses can be detected as soon as it reached to >25% of the total viral populations. By using this method, drug resistant viral populations were found to correlate with rebound of viral RNA level after prolonged antiretroviral therapies in HIV infected children. Conclusion This rapid and sensitive HIV 1 genotyping method can be used to predict and confirm emergence of HIV 1 drug resistance in HIV infected patients receiving HAART.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 2000年第4期325-329,共5页 Chinese Journal of Experimental and Clinical Virology
基金 国家自然科学基金资助(3000761748)
关键词 HIV-1 蛋白酶 逆转录酶 序列分析 耐药性 HIV-1 Reverse transcriptase Protease Sequence analysis Drag resistance
  • 引文网络
  • 相关文献

参考文献1

同被引文献20

  • 1刘静,尚红,姜拥军,张旻,张子宁,韩晓旭,王亚男,刁莹莹,代娣,耿文清.佳息患联合施多宁治疗HIV感染者/AIDS患者6个月效果及耐药性初步观察[J].中国艾滋病性病,2005,11(4):247-251. 被引量:7
  • 2刘小利,王少杨,翟嵩,庄严,李新红,康文臻,于旭,Marcus Altfeld,Bruce Walker,孙永涛.HAART治疗20例艾滋病患者疗效评估[J].中国艾滋病性病,2006,12(2):101-104. 被引量:27
  • 3Michaels SH, Clark R, Kissinger P, et al .Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection[J] .N Engl J Med, 1998,339(6) :405 - 406. 被引量:1
  • 4Montessori V,Press N,Harris M,et al. Adverse effects of antiretroviral therapy for HIV infection[J]. CMA J,2004,170 (2): 229 - 238. 被引量:1
  • 5Boden D, Hurley A,Zhang L, et al. HIV-1 drug resistance in newly infected individuals [ J ]. JAMA, 1999,282 (12): 1177 - 1179. 被引量:1
  • 6Deeks SG, Hellmann NS, Grant RM, et al. Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome[J] .J Infect Dis, 1999,179(6): 1375 - 1381. 被引量:1
  • 7Harrigan PR, Hertogs K, Verbiest W, et al. Baseline HIV drug resistance profile predicts response to ritonavir-saquinavir protease inhibitor therapy in a community setting[ J ]. AIDS, 1999,13(14) 1863 - 1871. 被引量:1
  • 8Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease[J] .Science, 1997,277(5322):112- 116. 被引量:1
  • 9Mahalingam M,Peakman ET, Davies A, et al. T cell activation and disease severity in HIV infection [ J ]. Clin Exp Immunol, 1993,93 (3):337 - 343. 被引量:1
  • 10Al-Harthi L, Voris J, Patterson BK, et al. Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients[ J ]. HIV Med, 2004, 5 ( 1 ): 55 - 65. 被引量:1

引证文献3

二级引证文献7

;
使用帮助 返回顶部